Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation
- 23 May 2022
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 164, e922-e928
Abstract
No abstract availableKeywords
Funding Information
- Christian Medical College Vellore
This publication has 27 references indexed in Scilit:
- Pleomorphic Xanthoastrocytoma: Natural History and Long‐Term Follow‐UpBrain Pathology, 2014
- BRAF‐Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 ExpressionBrain Pathology, 2013
- Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case seriesJournal of Neuro-Oncology, 2013
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature Genetics, 2013
- Prognostic Factors and Therapeutic Outcomes in 22 Patients with Pleomorphic XanthoastrocytomaJournal of Korean Neurosurgical Society, 2013
- Anaplastic PXA in adults: case series with clinicopathologic and molecular featuresJournal of Neuro-Oncology, 2012
- Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysisJournal of Neuro-Oncology, 2012
- BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic ImplicationsPLOS ONE, 2011
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaActa Neuropathologica, 2011
- Pleomorphic xanthoastrocytomaCancer, 1999